Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes

By sjmartinez • November 29, 2024

Vale C, Lourenço IM, Jordan G, Golovaty I, Torres H, Moin T, Buysschaert M, Neves JS, Bergman M. Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes. Diabetes Obes Metab. 2024 Nov 27. doi: 10.1111/dom.16077. Epub ahead of print. PMID: 39604324.

Tags: combination therapy, dual GIP/GLP‐1 receptor agonists, Endocrinology, GLP‐1 receptor agonists, Publications, SGLT2 inhibitors, Type 2 diabetes

Identifying pre-diabetes ‘hotspots’ in Northern California using geospatial analysis: opportunities to target diabetes prevention strategies and improve health equity

Thomas TW, Duru OK, Yassin M, Rodriguez LA, Moin T, Castellon-Lopez Y, Schmittdiel J. Identifying pre-diabetes 'hotspots' in Northern California using geospatial analysis: opportunities to[...]

Pro-inflammatory macrophage activation does not require inhibition of oxidative phosphorylation

Ball AB, Jones AE, Nguyễn KB, Rios A, Marx N, Hsieh WY, Yang K, Desousa BR, Kim KKO, Veliova M, Del Mundo ZM, Shirihai OS,[...]

Cushing’s Disease Clinical Phenotype and Tumor Behavior Vary with Age: Diagnostic and Perioperative Implications

Salcedo-Sifuentes JE, Shih R, Heaney AP, Bergsneider M, Wang MB, Donangelo I, Lee J, Delery W, Karsy M, Kshettry VR, Yuen KCJ, Evans JJ, Barkhoudarian[...]